1. Home
  2. ECOR vs AIRG Comparison

ECOR vs AIRG Comparison

Compare ECOR & AIRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECOR
  • AIRG
  • Stock Information
  • Founded
  • ECOR 2005
  • AIRG 1995
  • Country
  • ECOR United States
  • AIRG United States
  • Employees
  • ECOR N/A
  • AIRG N/A
  • Industry
  • ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • AIRG Radio And Television Broadcasting And Communications Equipment
  • Sector
  • ECOR Health Care
  • AIRG Technology
  • Exchange
  • ECOR Nasdaq
  • AIRG Nasdaq
  • Market Cap
  • ECOR 40.1M
  • AIRG 39.4M
  • IPO Year
  • ECOR 2018
  • AIRG 2016
  • Fundamental
  • Price
  • ECOR $4.65
  • AIRG $3.95
  • Analyst Decision
  • ECOR Strong Buy
  • AIRG Strong Buy
  • Analyst Count
  • ECOR 2
  • AIRG 2
  • Target Price
  • ECOR $25.50
  • AIRG $9.25
  • AVG Volume (30 Days)
  • ECOR 130.9K
  • AIRG 16.5K
  • Earning Date
  • ECOR 05-07-2025
  • AIRG 05-07-2025
  • Dividend Yield
  • ECOR N/A
  • AIRG N/A
  • EPS Growth
  • ECOR N/A
  • AIRG N/A
  • EPS
  • ECOR N/A
  • AIRG N/A
  • Revenue
  • ECOR $26,458,000.00
  • AIRG $58,381,000.00
  • Revenue This Year
  • ECOR $32.20
  • AIRG $1.27
  • Revenue Next Year
  • ECOR $46.27
  • AIRG $33.13
  • P/E Ratio
  • ECOR N/A
  • AIRG N/A
  • Revenue Growth
  • ECOR 41.54
  • AIRG 8.46
  • 52 Week Low
  • ECOR $5.02
  • AIRG $3.17
  • 52 Week High
  • ECOR $19.49
  • AIRG $10.34
  • Technical
  • Relative Strength Index (RSI)
  • ECOR 28.33
  • AIRG 48.85
  • Support Level
  • ECOR $6.01
  • AIRG $3.75
  • Resistance Level
  • ECOR $7.14
  • AIRG $4.24
  • Average True Range (ATR)
  • ECOR 0.77
  • AIRG 0.29
  • MACD
  • ECOR -0.05
  • AIRG 0.06
  • Stochastic Oscillator
  • ECOR 0.51
  • AIRG 57.97

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

About AIRG Airgain Inc.

Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.

Share on Social Networks: